Position in SCLX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$109
+$16 QoQ
Shares Held
14
-36.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 72 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $832,318,596 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
194,721 | $233,554,228 | |
| 2 | JNJ |
Johnson & Johnson
|
917,872 | $233,111,951 | |
| 3 | ABBV |
AbbVie Inc.
|
439,164 | $110,511,228 | |
| 4 | MRK |
Merck & Co., Inc.
|
455,515 | $58,533,677 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
442,389 | $55,891,426 | |
| 6 | GSK |
GSK plc
|
953,574 | $49,986,349 | |
| 7 | AMGN |
Amgen Inc
|
93,040 | $33,691,644 | |
| 8 | PFE |
Pfizer Inc
|
687,769 | $16,561,477 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109 | 14 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $93 | 14 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $170 | 14 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $275 | 14 | Shares | Sole | 2025-11-17 | |
| No filing history on record for this holder in this stock. | ||||||